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Abstract
Background: The association of rs16996148 single nucleotide polymorphism (SNP) in NCAN/CILP2/PBX4 and serum
lipid levels is inconsistent. Furthermore, little is known about the association of rs16996148 SNP and serum lipid
levels in the Chinese population. We therefore aimed to detect the association of rs16996148 SNP and several
environmental factors with serum lipid levels in the Guangxi Mulao and Han populations.
Method: A total of 712 subjects of Mulao nationality and 736 participants of Han nationality were randomly
selected from our stratified randomized cluster samples. Genotyping of the rs16996148 SNP was performed by
polymerase chain reaction and restriction fragment length polymorphism combined with gel electrophoresis, and
then confirmed by direct sequencing.
Results: The levels of apolipoprotein (Apo) B were higher in Mulao than in Han (P < 0.001). The frequencies of G and T
alleles were 87.2% and 12.8% in Mulao, and 89.9% and 10.1% in Han (P< 0.05); respectively. The frequencies of GG, GT and
TT genotypes were 76.0%, 22.5% and 1.5% in Mulao, and 81.2%, 17.4% and 1.4% in Han (P< 0.05); respectively. There were
no significant differences in the genotypic and allelic frequencies between males and females in both ethnic groups. The
levels of HDL-C, ApoAI, and the ratio of ApoAI to ApoB in Mulao were different between the GG and GT/TT genotypes in
males but not in females (P < 0.01 for all), the subjects with GT/TT genotypes had higher serum levels of HDL-C, ApoAI, and
the ratio of ApoAI to ApoB than the subjects with GG genotype. The levels of TC, TG, LDL-C, ApoAI, and ApoB in Han were
different between the GG and GT/TT genotypes in males but not in females (P < 0.05-0.001), the T allele carriers had higher
serum levels of TC, TG, LDL-C, ApoAI, and ApoB than the T allele noncarriers. The levels of HDL-C, ApoAI, and the ratio of
ApoAI to ApoB in Mulao were correlated with the genotypes in males (P < 0.05-0.01) but not in females. The levels of TC,
T G ,H D L - C ,L D L - C ,A p o A Ia n dA p o Bi nH a nw e r e associated with the genotypes in males (P < 0.05-0.001) but not in females.
Serum lipid parameters were also correlated with several enviromental factors in both ethnic groups (P < 0.05-0.001).
Conclusions: The genotypic and allelic frequencies of rs16996148 SNP and the associations of the SNP and serum
lipid levels are different in the Mulao and Han populations. Sex (male)-specific association of rs16996148 SNP in the
NCAN/CILP2/PBX4 and serum lipid levels is also observed in the both ethnic groups.
Introduction
Coronary artery disease (CAD) is the leading cause of
morbidity and mortality in industrialized countries, and
the prevalence of this disease is increasing rapidly in
developing countries [1]. Consistent and compelling
evidence has demonstrated association between dyslipi-
demia and CAD incidence worldwide [2-4]. It is well-
established that dyslipidemia is a complex trait caused
by multiple environmental and genetic factors [5-7] and
their interactions [8,9]. Family studies suggest that in
many populations, about half of the variation in serum
lipid profiles is genetically determined [10,11], and it is
clear that serum lipid levels a r es t r o n g l yi n f l u e n c e db y
the genetic constitution of each individual.
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different populations have identified more than 95 loci
associated with serum lipid levels [5,12-46]. Common
variants at these loci together explain < 10% of variation
in each lipid trait [23,24,40]. Rare variants with large
individual effects may also contribute to the heritability
of lipid traits [40]. In addition, GWAS also discovered a
number of novel loci that influence serum lipid pheno-
types [15,17,21,39]. One of these newly identified single
nucleotide polymorphisms (SNPs) is rs16996148 SNP in
the NCAN/CILP2/PBX4. rs16996148 is located on chro-
mosome 19p13 in an intergenic region between CILP2
and PBX4, which encodes a cartilage intermediate layer
protein and a putative transcription factor expressed in
testis, respectively [47,48]. Neurocan (NCAN) is a ner-
vous system-specific proteoglycan involved in neuronal
pattern formation, remodeling of neuronal networks and
regulation of synaptic plasticity [49], with no obvious
relation to LDL-C or TG concentrations. The roles of
CILP2 and PBX4 in lipid metabolism are also unclear at
this time [50,51]. In Europeans, however, rs16996148 in
NCAN/CILP2/PBX4 has been showed significant asso-
ciations with LDL-C and TG concentrations [15,17]. Tai
et al. [51] also reported that rs16996148 SNP was signif-
icantly associated with LDL-C and HDL-C concentra-
tions in the Malays under a recessive model of
inheritance. Nevertheless, Nakayama et al. [50] did not
observe significant associations between rs16996148
SNP and blood lipid profiles in the Japanese population.
These results suggest that the ability of associations to
generalize across other racial/ethnic populations varied
greatly, some of these GWAS-identified variants may
not be functional and are more likely to be in linkage
disequilibrium with the functional variants.
China is a multiethnic country with 56 ethnic groups.
Han nationality is the largest ethnic group, and Mulao
nationality is one of the 55 minorities with population
of 207,352 according to the fifth national census statis-
tics of China in 2000. Ninety percent of them live in the
Luocheng Mulao Autonomous County, Guangxi Zhuang
Autonomous Region, People’s Republic of China. The
history of this minority can be traced back to the Jin
Dynasty (AD 265-420). In a previous study, Xu et al.
[52] showed that the genetic relationship between
Mulao nationality and other minorities in Guangxi was
much closer than that between Mulao and Han or
Uighur nationality. To the best of our knowledge, how-
ever, the association of rs16996148 SNP and serum lipid
levels has not been previously reported in the Chinese
population. Therefore, the aim of the present study was
to detect the association of rs16996148 SNP in the
NCAN/CILP2/PBX4 and several environmental factors
with serum lipid profiles in the Mulao and Han
populations.
Materials and Methods
Participants
Participants in the present study included 712 indivi-
duals of Mulao nationality living in Luocheng Mulao
Autonomous County, Guangxi Zhuang Autonomous
Region, People’s Republic of China. They were randomly
selected from our previous stratified randomized cluster
samples [53]. The ages of the participants ranged from
15 to 86 years, with an average age of 51.81 ± 14.76
years. There were 330 males (46.3%) and 382 females
(53.7%). All participants were rural agricultural workers.
D u r i n gt h es a m ep e r i o d ,at o t a lo f7 3 6p e o p l eo fH a n
nationality who reside in the same villages were also
randomly selected from our previous stratified rando-
mized cluster samples. The average age of the subjects
was 51.77 ± 14.96 years (range 15 to 86). There were
308 men (41.8%) and 428 women (58.2%). All of them
were also rural agricultural workers. All study subjects
were essentially healthy and had no evidence of any
chronic illness, including hepatic, renal, or thyroid. The
participants with a history of heart attack or myocardial
infarction, stroke, congestive heart failure, diabetes or
fasting blood glucose ≥ 7.0 mmol/L determined by glu-
cose meter were excluded from the analyses. The parti-
cipants were not taking medications known to affect
serum lipid levels (lipid-lowering drugs such as statins
or fibrates, beta-blockers, diuretics, or hormones). The
experimental design was approved by the Ethics Com-
mittee of the First Affiliated Hospital, Guangxi Medical
University. All participants in this study provided writ-
ten informed consent.
Epidemiological survey
The survey was carried out using internationally stan-
dardized methods [54]. All participants underwent a
complete history, physical examination, and laboratory
assessment of cardiovascular risk factors, including
cigarette smoking, family history of myocardial infarc-
tion, blood pressure, presence of diabetes mellitus.
I n f o r m a t i o no nd e m o g r a p h i c s, socioeconomic status,
and lifestyle factors was collected with standardized
questionnaires. The alcohol information included ques-
t i o n sa b o u tt h en u m b e ro fl i a n g s( a b o u t5 0g )o fr i c e
wine, corn wine, rum, beer, or liquor consumed during
the preceding 12 months. Alcohol consumption was
categorized into groups of grams of alcohol per day: ≤
25 and > 25. Smoking status was categorized into
groups of cigarettes per day: ≤ 20 and > 20. At the phy-
sical examination, several parameters were measured.
Sitting blood pressure was measured three times with
the use of a mercury sphygmomanometer after the sub-
jects had a 5-minute rest, and the average of the three
measurements was used for the level of blood pressure.
Systolic blood pressure was determined by the first
Yan et al. Lipids in Health and Disease 2011, 10:248
http://www.lipidworld.com/content/10/1/248
Page 2 of 15Korotkoff sound, and diastolic blood pressure by the
fifth Korotkoff sound. Body weight, to the nearest 50
grams, was measured using a portable balance scale.
Subjects were weighed without shoes and in a minimum
of clothing. Height was measured, to the nearest 0.5 cm,
using a portable steel measuring device. From these two
measurements body mass index (BMI, kg/m
2)w a s
calculated.
Determination of serum lipid levels
Venous blood samples were collected after an overnight
(at least 12 hours) fast. A part of the sample (2 mL) was
collected into glass tubes and allowed to clot at room
temperature, and used to determine serum lipid levels.
Another part of the sample (3 mL) was transferred to
tubes with anticoagulate solution (4.80 g/L citric acid,
14.70 g/L glucose, and 13.20 g/L tri-sodium citrate) and
used to extract DNA. Serum TC, TG, HDL-C, and
LDL-C levels in the samples were measured according
to standard enzymatic methods. Serum ApoAI and
ApoB levels were detected by the immunoturbidimetric
immunoassay. All determinations were performed with
an autoanalyzer (Type 7170A; Hitachi Ltd., Tokyo,
Japan) in the Clinical Science Experiment Center of the
First Affiliated Hospital, Guangxi Medical University
[6,7].
DNA preparation and genotyping
Genomic DNA was isolated from peripheral blood leu-
kocytes using the phenol-chloroform method [8,9]. The
extracted DNA was stored at -80°C until analysis. Geno-
typing of the rs16996148 SNP was performed by poly-
merase chain reaction and restriction fragment length
polymorphism (PCR-RFLP). PCR amplification was per-
formed using 5’-CATCCAGCATTTAGAGGTGTGA-3’
and 5’-CTAGGGCAAAGGAAGTGTTTC-3’ (Sangon,
Shanghai, People’s Republic of China) as the forward
and reverse primer pairs; respectively. Each amplification
reaction was performed using 100 ng (2 μL) of genomic
DNA in 25 μL of reaction mixture consisting of 1.0 μL
of each primer (10 μmo1/L), 12.5 μL 2 × Taq PCRMas-
terMix (constituent: 0.1 U Taq polymerase/μL, 500 μM
dNTP each, 20 mM Tris-HCl, pH 8.3, 100 mM KCl, 3
mM MgCl2, and stabilizers), and nuclease-free water 8.5
μL. After initial denaturizing at 95°C for 5 min, the reac-
tion mixture was subjected to 33 cycles of denaturation
at 95°C for 30 s, annealing at 60°C for 45 s and exten-
sion 1 min at 72°C, followed by a final 5 min extension
at 72°C. After electrophoresis on a 2.0% agarose gel with
0.5 μg/mL ethidium bromide, the amplification products
were visualized under ultraviolet light. Then 2.5 U of
Hin1II restriction enzyme, 8 μL nuclease-free water and
1 μL of 10 × buffer solution were added directly to the
PCR products (5 μL) and digested at 37°C overnight.
After restriction enzyme digestion of the amplified
DNA, genotypes were identified by electrophoresis on
2.5% agarose gel and visualized with ethidium-bromide
staining ultraviolet illumination. Genotypes were scored
by an experienced reader blinded to epidemiological
data and serum lipid levels.
DNA sequencing
Six samples (GG, GT and TT genotypes in two; respec-
tively) detected by the PCR-RFLP were also confirmed
by direct sequencing. The PCR products were purified
by low melting point gel electrophoresis and phenol
extraction, and then the DNA sequences were analyzed
in Shanghai Sangon Biological Engineering Technology
& Services Co., Ltd., People’s Republic of China.
Diagnostic criteria
The normal values of serum TC, TG, HDL-C, LDL-C,
ApoAI, ApoB levels and the ratio of ApoAI to ApoB in
our Clinical Science Experiment Center were 3.10-5.17,
0.56-1.70, 1.16-1.42, 2.70-3.10 mmol/L, 1.20-1.60, 0.80-
1.05 g/L, and 1.00-2.50; respectively [53]. The indivi-
duals with TC > 5.17 mmol/L and/or TG > 1.70 mmol/
L were defined as hyperlipidemic [6,7,53]. Hypertension
was diagnosed according to the criteria of 1999 World
Health Organization-International Society of Hyperten-
sion Guidelines for the management of hypertension
[55,56]. The diagnostic criteria of overweight and obesity
were according to the Cooperative Meta-analysis Group
of China Obesity Task Force. Normal weight, over-
weight and obesity were defined as a BMI < 24, 24-28,
and > 28 kg/m
2; respectively [57].
Statistical analysis
The statistical analyses were done with the statistical
software package SPSS 13.0 (SPSS Inc., Chicago, Illi-
nois). Quantitative variables were expressed as mean ±
standard deviation (serum TG levels were presented as
medians and interquartile ranges). Qualitative variables
were expressed as percentages. Allele frequency was
determined via direct counting, and the standard good-
ness-of-fit test was used to test the Hardy-Weinberg
equilibrium. Difference in genotype distribution between
the groups was obtained using the chi-square test. The
difference in general characteristics between two ethnic
groups was tested by the Student’su n p a i r e dt-test. The
association of genotypes and serum lipid parameters was
tested by analysis of covariance (ANCOVA). Age, sex,
BMI, blood pressure, alcohol consumption, and cigarette
smoking were included in the statistical models as cov-
ariates. Multiple linear regression analyses adjusted for
age, sex, BMI, blood pressure, alcohol consumption, and
cigarette smoking were also performed to assess the
association of serum lipid levels with genotypes (GG =
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environment factors. A P v a l u eo fl e s st h a n0 . 0 5w a s
considered statistically significant.
Results
General characteristics and serum lipid levels
Table 1 shows the general characteristics and serum
lipid levels of the study population. The levels of ApoB
and the percentages of subjects who consumed alcohol
were higher but the levels of BMI and diastolic blood
pressure were lower in Mulao than in Han (P <0 . 0 5 -
0.001). There were no significant differences in the
levels of age, body height, weight, systolic blood pres-
sure, pulse pressure, blood glucose, TC, TG, HDL-C,
LDL-C, ApoAI; the ratio of ApoAI to ApoB; the percen-
tages of subjects who smoked cigarettes; and the ratio of
male to female between the two ethnic groups (P >0 . 0 5
for all).
Electrophoresis and genotypes
After the genomic DNA of the samples was amplified by
PCR and imaged by 2.0% agarose gel electrophoresis, the
PCR products of 242 bp nucleotide sequences could be
seen in the samples (Figure 1). The genotypes identified
were named according to the presence (T allele) or
absence (G allele) of the enzyme restriction sites. Thus,
GG genotype is heterozygote for the absence of the site
(bands at 242 bp), GT genotype is heterozygote for the
absence and presence of the site (bands at 242-, 221-
and 21-bp), and TT genotype is homozygote for the pre-
sence of the site (bands at 221- and 21- bp; Figure 2).
The 21 bp fragments were invisible in the gel owing to
its fast migration speed. The genotype distribution of
rs16996148 SNP followed the Hardy-Weinberg
equilibrium.
Nucleotide sequences
The results were shown as GG, GT and TT genotypes
of the rs16996148 SNP by PCR-RFLP, the genotypes
were also confirmed by sequencing (Figure 3);
respectively.
Genotypic and allelic frequencies
The genotypic and allelic frequencies of rs16996148 SNP
in the both ethnic groups are shown in Table 2. The G and
T allele frequencies of rs16996148 SNP were 87.2% and
12.8% in Mulao, and 89.9% and 10.1% in Han (P< 0.05);
respectively. The frequencies of GG, GT and TT genotypes
were 76.0%, 22.5% and 1.5% in Mulao, and 81.2%, 17.4%
and 1.4% in Han (P< 0.05); respectively. There were no sig-
nificant differences in the genotypic and allelic frequencies
between males and females in both groups.
Genotypes and serum lipid levels
As shown in Table 3, the levels of HDL-C in Mulao
were different among the three genotypes (P < 0.05), the
T allele carriers had higher serum HDL-C levels than
the T allele noncarriers. When serum lipid parameters
in Mulao were analyzed according to sex, we found that
the levels of HDL-C, ApoAI, and the ratio of ApoAI to
ApoB in males but not in females were different
between the GG and GT/TT genotypes (P <0 . 0 1f o r
all), the subjects with GT/TT genotypes had higher
serum levels of HDL-C, ApoAI, and the ratio of ApoAI
to ApoB than the subjects with GG genotype.
In the Han population, the levels of TC, TG, LDL-C
and ApoAI among the three genotypes, or the levels of
T C ,L D L - C ,A p o A I ,a n dA p o Bb e t w e e nt h eG Ga n d
GT/TT genotypes were different (P < 0.05-0.001), the T
allele carriers had higher serum TC, TG, LDL-C, ApoAI
Table 1 The general characteristics and serum lipid levels
in the Mulao and Han populations
Parameter Mulao Han
Chinese
t (c
2) P
Number 712 736 - -
Male/female 330/382 308/428 2.974 0.090
Age (years) 51.81 ±
14.76
51.77 ±
14.96
0.058 0.954
Height (cm) 155.44 ±
7.72
154.71 ±
7.93
1.774 0.076
Weight (kg) 52.88 ± 9.03 53.72 ± 8.85 -1.803 0.072
Body mass index (kg/m
2) 21.83 ± 3.00 22.43 ± 3.32 -3.600 0.000
Systolic blood pressure
(mmHg)
129.16 ±
21.47
129.58 ±
18.67
-0.397 0.692
Diastolic blood pressure
(mmHg)
80.90 ±
11.60
82.27 ±
11.05
-2.298 0.022
Pulse pressure (mmHg) 48.25 ±
16.07
47.30 ±
14.19
1.187 0.235
Blood glucose 5.96 ± 1.54 5.96 ± 1.61 -0.096 0.923
Cigarette smoking [n (%)]
Nonsmoker 519 (72.9) 532 (72.3)
≤ 20 cigarettes/day 159 (22.3) 178 (24.2)
> 20 cigarettes/day 34 (5.8) 26 (3.5) 1.901 0.386
Alcohol consumption [n (%)]
Nondrinker 516 (72.5) 565 (76.8)
≤ 25 g/day 67 (9.4) 79 (10.7)
> 25 g/day 129 (18.1) 92 (12.5) 9.007 0.011
Total cholesterol (mmol/L) 5.02 ± 1.29 5.02 ± 1.03 0.040 0.968
Triglyceride (mmol/L) 1.05 (0.81) 1.07 (0.91) -0.562 0.574
HDL-C (mmol/L) 1.75 ± 0.46 1.75 ± 0.53 -0.171 0.864
LDL-C (mmol/L) 2.92 ± 0.88 2.91 ± 0.85 0.337 0.736
Apolipoprotein (Apo) AI
(g/L)
1.33 ± 0.40 1.35 ± 0.26 -1.456 0.146
ApoB (g/L) 0.97 ± 0.54 0.86 ± 0.20 5.202 0.000
ApoAI/ApoB 1.61 ± 0.95 1.66 ± 0.51 -1.409 0.159
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein
cholesterol. The value of Triglyceride was presented as median (interquartile
range), the difference between the two ethnic groups was determined by the
Wilcoxon-Mann-Whitney test.
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serum lipid parameters in Han were stratified according
to sex, we showed that the levels of TC, TG, LDL-C,
ApoAI, and ApoB in males but not in females were
different between the GG and GT/TT genotypes (P <
0.05-0.001), the subjects with GT/TT genotypes had
higher serum levels of TC, TG, LDL-C, ApoAI, and
ApoB than the subjects with GG genotype.
Figure 1 Electrophoresis of PCR products of the samples.L a n eM ,1 0 0b pm a r k e rl a d d e r ;l a n e s1 - 5, samples. The 242 bp bands are the
target genes.
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The correlation between the genotypes of rs16996148
SNP and serum lipid parameters in Mulao and Han is
shown in Table 4. The levels of HDL-C, ApoAI, and
the ratio of ApoAI to ApoB in Mulao were correlated
with the genotypes in males (P < 0.05-0.01) but not in
females. The levels of TC, TG, HDL-C, LDL-C,
ApoAI and ApoB in Han were associated with the
genotypes in males (P < 0.05-0.001) but not in
females.
Figure 2 Genotyping of rs16996148 polymorphism in the NCAN gene. Lane M, 100 bp marker ladder; lanes 1 and 2, GG genotype (242 bp);
lanes 3 and 4, GT genotype (242-, 221- and 21-bp); and lanes 5 and 6, TT genotype (221- and 21-bp). The 21 bp fragments were invisible in the
gel owing to its fast migration speed.
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eral environment factors such as age, gender, alcohol
consumption, cigarette smoking, blood pressure, blood
glucose, and BMI in both ethnic groups (P < 0.05-0.001;
Table 5).
Discussion
The present study shows that serum ApoB levels were
higher in Mulao than in Han nationalities. There were
no significant differences in the remaining serum lipid
parameters between the two ethnic groups. It is well
known that dyslipidemia is the result of a combination
of genetic and environmental factors [6-9]. Both family
and twin studies suggest that in many populations,
about 40-60% of the variation in serum lipid profiles is
genetically determined [10,11], and it is clear that LDL-
C, HDL-C and TG concentrations are strongly influ-
enced by the genetic constitution of each individual.
The engagements of Mulao nationality were family-
arranged in childhood, usually with the girl being four
or five years older than the boy. There was a preference
for marriage to mother’sb r o t h e r ’s daughter. Engage-
ment and marriage were marked by bride-wealth
Figure 3 A part of the nucleotide sequence of rs16996148 SNP. (A) GG genotype; (B) GT genotype; (C) TT genotype.
Table 2 The genotypic and allelic frequencies of
rs16996148 SNP the Mulao and Han populations [n (%)]
Group n Genotype Allele
GG GT TT G T
Mulao 712 541
(76.0)
160
(22.5)
11
(1.5)
1242
(87.2)
182
(12.8)
Han 736 598
(81.2)
128
(17.4)
10
(1.4)
1324
(89.9)
148
(10.1)
c
2 - 6.060 5.329
P - 0.048 0.022
Mulao
Male 330 243
(73.6)
79 (24.0) 8 (2.4) 565 (85.6) 95 (14.4)
Female 382 298
(78.0)
81 (21.2) 3 (0.8) 677 (88.6) 87 (11.4)
c
2 - 4.113 2.871
P - 0.128 0.095
Han
Male 308 246
(79.9)
60 (19.5) 2 (0.6) 552 (89.6) 64 (10.4)
Female 428 352
(82.2)
68 (15.9) 8 (1.9) 772 (90.2) 84 (9.8)
c
2 - 3.415 0.132
P - 0.181 0.726
Yan et al. Lipids in Health and Disease 2011, 10:248
http://www.lipidworld.com/content/10/1/248
Page 7 of 15payments. Marriage ceremonies were held when the girl
reached puberty. She remained with her natal family
until her first child was born. Till then she was free to
join the young men and women who came together for
responsive singing, flirtations, and courtships at festival
times. Divorce and remarriage were permitted, with little
restriction. The two-generation household is the most
common unit of residence. Households are under the
control of the father, and divide when the sons marry,
with only the youngest son remaining with the parents.
Therefore, we believe that the genetic background and
some lipid-associated genetic variants in this population
may be different from those in Han nationality.
The genotypic and allelic frequencies of rs16996148
SNP in the NCAN/CILP2/PBX4 in diverse racial/ethnic
groups are inconsistent. The frequency of T allele was 8%
Table 3 The genotypes of rs16996148 SNP and serum lipid levels in the Mulao and Han populations
Genotype n TC
(mmol/L)
TG
(mmol/L)
HDL-C
(mmol/L)
LDL-C
(mmol/L)
ApoAI
(g/L)
ApoB
(g/L)
ApoAI/
ApoB
Mulao
GG 541 5.03 ± 1.35 1.07(0.84) 1.72 ± 0.44 2.94 ± 0.88 1.31 ± 0.40 0.98 ± 0.56 1.59 ± 1.01
GT 160 4.99 ± 1.11 1.02(0.73) 1.83 ± 0.50 2.88 ± 0.91 1.37 ± 0.41 0.94 ± 0.49 1.68 ± 0.73
TT 11 4.91 ± 0.85 1.18(0.89) 1.89 ± 0.20 2.78 ± 0.74 1.32 ± 0.47 0.93 ± 0.46 1.54 ± 0.62
F - 0.108 1.338 3.910 0.284 1.593 0.564 0.685
P - 0.897 0.512 0.020 0.752 0.204 0.569 0.505
GG 541 5.03 ± 1.35 1.07(0.84) 1.72 ± 0.44 2.94 ± 0.88 1.31 ± 0.40 0.98 ± 0.56 1.59 ± 1.01
GT/TT 171 4.99 ± 1.09 1.03(0.74) 1.83 ± 0.49 2.87 ± 0.90 1.37 ± 0.41 0.94 ± 0.49 1.67 ± 0.73
F - 0.045 -1.154 7.483 0.398 2.981 1.028 1.304
P - 0.832 0.248 0.006 0.528 0.085 0.311 0.254
Han
GG 598 4.95 ± 0,98 1.07(0.86) 1.74 ± 0.55 2.86 ± 0.81 1.35 ± 0.26 0.85 ± 0.20 1.67 ± 0.52
GT 128 5.28 ± 1.16 1.15(1.23) 1.76 ± 0.44 3.13 ± 0.94 1.37 ± 0.23 0.90 ± 0.21 1.59 ± 0.43
TT 10 5.40 ± 1.38 0.84(0.49) 2.17 ± 0.41 3.05 ± 1.26 1.62 ± 0.33 0.83 ± 0.26 2.15 ± 0.79
F 7.467 6.323 2.473 5.504 5.845 2.909 1.940
P 0.001 0.042 0.085 0.004 0.003 0.055 0.145
GG 598 4.95 ± 0.98 1.07(0.86) 1.74 ± 0.55 2.86 ± 0.81 1.35 ± 0.26 0.85 ± 0.20 1.67 ± 0.52
GT/TT 138 5.29 ± 1.17 1.15(1.18) 1.79 ± 0.45 3.12 ± 0.96 1.38 ± 0.25 0.89 ± 0.21 1.63 ± 0.49
F - 12.684 -1.555 1.389 10.222 4.955 5.469 0.091
P - 0.000 0.120 0.239 0.001 0.026 0.020 0.763
Mulao/male
GG 243 5.18 ± 1.50 1.15(1.07) 1.72 ± 0.45 2.96 ± 0.86 1.32 ± 0.44 1.04 ± 0.62 1.48 ± 0.65
GT/TT 87 5.08 ± 1.64 1.08(0.86) 1.86 ± 0.58 2.84 ± 0.86 1.44 ± 0.40 0.98 ± 0.52 1.70 ± 0.77
F - 0.276 -0.341 7.151 1.375 7.126 0.574 9.195
P - 0.600 0.733 0.008 0.245 0.008 0.449 0.003
Mulao/female
GG 298 4.91 ± 1.21 1.03(0.65) 1.72 ± 0.44 2.92 ± 0.89 1.31 ± 0.37 0.93 ± 0.50 1.68 ± 1.22
GT/TT 84 4.89 ± 1.01 0.95(0.60) 1.80 ± 0.38 2.90 ± 0.95 1.29 ± 0.41 0.89 ± 0.46 1.63 ± 0.68
F - 0.110 -1.648 1.134 0.181 0.104 0.106 0.163
P - 0.740 0.099 0.288 0.671 0.747 0.745 0.686
Han/male
GG 246 5.08 ± 0.90 1.14(0.92) 1.69 ± 0.42 2.90 ± 0.77 1.36 ± 0.28 0.90 ± 0.19 1.58 ± 0.47
GT/TT 62 5.59 ± 1.12 1.71(1.61) 1.75 ± 0.45 3.26 ± 0.78 1.44 ± 0.28 0.97 ± 0.23 1.56 ± 0.46
F - 13.935 -2.649 2.569 8.390 7.843 4.675 0.248
P - 0.000 0.008 0.110 0.004 0.005 0.031 0.619
Han/female
GG 352 4.86 ± 1.02 1.00(0.81) 1.78 ± 0.62 2.83 ± 0.84 1.33 ± 0.24 0.81 ± 0.20 1.74 ± 0.54
GT/TT 76 5.05 ± 1.16 0.93(0.80) 1.81 ± 0.46 3.01 ± 1.08 1.34 ± 0.21 0.84 ± 0.18 1.69 ± 0.50
F - 3.262 -0.389 0.133 3.680 0.141 1.239 0.548
P - 0.072 0.698 0.715 0.056 0.707 0.266 0.459
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B
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Page 8 of 15in European Americans, 15% in African Americans, 4% in
American Indians, 6% in Mexican Americans and Hispa-
nics [40], and 12% in Japanese [50]. The minor allele fre-
quency in the Malay population was 17% [51]. In the
present study, we showed that the T allele frequency of
rs16996148 SNP was higher in Mulao than in Han
(12.8% vs. 10.1%, P< 0.05). The frequencies of GG, GT
and TT genotypes were also different between the two
ethnic groups (P< 0.05). There were no significant differ-
ences in the genotypic and allelic frequencies between
males and females in both ethnic groups. These results
indicate that the prevalence of the T allele variant of the
rs16996148 SNP may have a racial/ethnic specificity.
The potential relationship between the rs16996148
SNP and plasma or serum lipid levels in humans has
been evaluated in several previous studies (GWAS).
However, previous findings on the association of this
SNP with the changes in plasma lipid levels are incon-
sistent. The rs16996148 SNP in NCAN/CILP2/PBX4 has
been shown significant associations with LDL-C and TG
concentrations in Europeans [15,17]. The minor allele
(T allele) of rs16996148 SNP was associated with lower
concentrations of both LDL-C (by ~16 mg/dl) and TG
[15]. Tai et al. [51] also reported that rs16996148 SNP
was significantly associated with lower LDL-C and
elevated HDL-C concentrations in the Malays under a
recessive model of inheritance [51]. Nevertheless,
Nakayama et al. [50] did not observe significant associa-
tions between rs16996148 and blood lipid profiles in the
Japanese population. In the current study, we found that
the levels of HDL-C, ApoAI, and the ratio of ApoAI to
ApoB in Mulao were different between the GG and GT/
TT genotypes in males but not in females, the subjects
with GT/TT genotypes had higher serum levels of
HDL-C, ApoAI, and the ratio of ApoAI to ApoB than
the subjects with GG genotype. The levels of TC, TG,
LDL-C, ApoAI, and ApoB in Han were different
between the GG and GT/TT genotypes in males but
not in females, the T allele carriers had higher serum
levels of TC, TG, LDL-C, ApoAI, and ApoB than the T
allele noncarriers. The levels of HDL-C, ApoAI, and the
ratio of ApoAI to ApoB in Mulao were correlated with
the genotypes in males but not in females. The levels of
TC, TG, HDL-C, LDL-C, ApoAI and ApoB in Han were
correlated with the genotypes in males but not in
females. These findings suggest that there is a sex-speci-
fic association of rs16996148 SNP in the NCAN/CILP2/
PBX4 and serum lipid levels in our study populations.
It is well known that environmental factors such as
dietary patterns, lifestyle, obesity, physical activity, and
Table 4 Correlation between the genotypes of rs16996148 SNP and serum lipid parameters in the Mulao and Han
populations
Lipid parameter Relative factor Unstandardized coefficient Std. error Standardized coefficient tP
Mulao plus Han
TC Genetype 0.137 0.065 0.053 2.106 0.035
HDL-C Genetype 0.082 0.028 0.075 2.924 0.004
ApoAI Genetype 0.049 0.019 0.066 2.577 0.010
Mulao
HDL-C Genetype 0.091 0.035 0.094 2.609 0.009
Han
TC Genetype 0.322 0.082 0.136 3.934 0.000
TG Genetype 0.335 0.161 0.074 2.082 0.038
LDL-C Genetype 0.234 0.068 0.119 3.424 0.001
ApoAI Genetype 0.057 0.020 0.096 2.802 0.005
ApoB Genetype 0.038 0.015 0.081 2.482 0.013
Mulao/male
HDL-C Genetype 0.133 0.050 0.137 2.647 0.009
ApoAI Genetype 0.109 0.045 0.128 2.419 0.016
ApoAI/ApoB Genetype 0.192 0.072 0.141 2.676 0.008
Han/male
TC Genetype 0.513 0.122 0.223 4.203 0.000
TG Genetype 0.860 0.345 0.139 2.493 0.013
HDL-C Genetype 0.114 0.053 0.113 2.159 0.032
LDL-C Genetype 0.327 0.101 0.176 3.241 0.001
ApoAI Genetype 0.107 0.033 0.159 3.268 0.001
ApoB Genetype 0.058 0.024 0.121 2.388 0.018
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Page 9 of 15Table 5 Correlation between environmental factors and serum lipid parameters in the Mulao and Han populations
Lipid parameter Relative factor Unstandardized coefficient Std. error Standardized coefficient tP
Mulao plus Han
TC Body mass index 0.053 0.010 0.145 5.530 0.000
Age 0.012 0.002 0.155 5.960 0.000
Alcohol consumption 0.177 0.040 0.113 4.379 0.000
Diastolic blood pressure 0.006 0.003 0.054 2.004 0.045
TG Body mass index 0.107 0.016 0.170 6.582 0.000
Gender -0.309 0.127 -0.077 -2.445 0.015
Alcohol consumption 0.214 0.085 0.079 2.509 0.012
Blood glucose 0.080 0.032 0.063 2.464 0.014
HDL-C Body mass index -0.030 0.004 -0.191 -7.412 0.000
Alcohol consumption 0.105 0.021 0.157 4.981 0.000
Gender 0.105 0.031 0.105 3.348 0.001
Age 0.002 0.001 0.058 2.261 0.024
LDL-C Body mass index 0.051 0.007 0.186 7.334 0.000
Age 0.010 0.002 0.174 6.673 0.000
Blood glucose 0.030 0.014 0.054 2.082 0.038
ApoAI Alcohol consumption 0.131 0.014 0.287 9.143 0.000
Body mass index -0.010 0.003 -0.090 -3.483 0.001
Age 0.002 0.001 0.073 2.863 0.004
Gender 0.061 0.021 0.089 2.850 0.004
Nation -0.045 0.017 -0.066 -2.586 0.010
ApoB Body mass index 0.021 0.003 0.165 6.425 0.000
Nation 0.121 0.021 0.147 5.768 0.000
Blood glucose 0.024 0.007 0.092 3.611 0.000
Gender -0.075 0.021 -0.091 -3.537 0.000
Pulse pressure 0.001 0.001 0.054 2.109 0.035
ApoAI/ApoB Body mass index -0.047 0.006 -0.197 -7.634 0.000
Blood glucose -0.036 0.013 -0.076 -2.904 0.004
Gender 0.207 0.048 0.135 4.320 0.000
Alcohol consumption 0.118 0.032 0.115 3.663 0.000
Age -0.003 0.001 -0.066 -2.526 0.012
Nation -0.087 0.039 -0.058 -2.247 0.025
Mulao
TC Body mass index 0.066 0.016 0.153 4.163 0.000
Age 0.011 0.003 0.126 3.455 0.001
Alcohol consumption 0.179 0.061 0.108 2.953 0.003
TG Body mass index 0.126 0.025 0.186 5.088 0.000
Alcohol consumption 0.407 0.095 0.156 4.275 0.000
HDL-C Body mass index -0.037 0.006 -0.244 -6.727 0.000
Alcohol consumption 0.066 0.021 0.113 3.115 0.002
LDL-C Body mass index 0.054 0.011 0.182 4.997 0.000
Age 0.009 0.002 0.146 3.998 0.000
ApoAI Alcohol consumption 0.095 0.019 0.184 5.009 0.000
Age 0.002 0.001 0.088 2.393 0.017
ApoB Body mass index 0.026 0.007 0.142 3.830 0.000
Gender -0.087 0.040 -0.080 -2.16 0.031
ApoAI/ApoB Body mass index -0.041 0.012 -0.129 -3.468 0.001
Blood glucose -0.052 0.023 -0.084 -2.260 0.024
Han Chinese
TC Diastolic blood pressure 0.014 0.003 0.147 3.981 0.000
Age 0.012 0.002 0.180 5.005 0.000
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Page 10 of 15hypertension are all strongly related with serum lipid
levels [6,7]. Furthermore, exposure to different lifestyles
and environments in our populations resident in
Guangxi may further modify the effect of genetic varia-
tion on blood lipids. In the present study, we also
showed that serum lipid parameters were correlated
with age, sex, alcohol consumption, cigarette smoking,
BMI, and blood pressure in both ethnic groups. These
data suggest that the environmental factors also play an
important role in determining serum lipid levels in our
populations. Although rice and corn are the staple foods
in both ethnic groups, the people of Mulao nationality
like to eat cold foods along with acidic and spicy dishes,
so bean soy sauce and pickled vegetables are among
their most popular dishes. They also like to eat animal
offals which contain abundant saturated fatty acid. The
effects of dietary macronutrients on serum lipid levels
and their effects on CAD have been extensively studied
[58-62]. Almost 40 y ago, the Puerto Rican Heart Study
found lower mean concentrations of TC and TG in
Puerto Ricans than in subjects in the Framingham Heart
Study [63]. Among urban Puerto Rican men, TC was
positively associated with the percentage of energy from
total fat, saturated fatty acids (SFAs), simple sugars, and
protein and negatively associated with the percentage of
energy from polyunsaturated fatty acids (PUFAs), total
carbohydrate, and PUFA/SFA. Overall, diet and relative
weight can account for at most 6% of the variability in
serum cholesterol observed, with at most 2.5% of the
variability due diet alone [63].
Conclusion
T h ep r e s e n ts t u d ys h o w st h a tt h eTa l l e l ef r e q u e n c yo f
rs16996148 SNP in the NCAN/CILP2/PBX4 is signifi-
cantly higher in Mulao than in Han. The frequencies of
GG, GT and TT genotypes are also different between
Table 5 Correlation between environmental factors and serum lipid parameters in the Mulao and Han populations
(Continued)
Body mass index 0.041 0.011 0.133 3.688 0.000
Alcohol consumption 0.188 0.052 0.127 3.610 0.000
TG Body mass index 0.082 0.022 0.138 3.744 0.000
Blood glucose 0.151 0.043 0.125 3.500 0.000
Gender -0.474 0.144 -0.119 -3.301 0.001
Diastolic blood pressure 0.017 0.006 0.094 2.560 0.011
HDL-C Body mass index -0.022 0.006 -0.141 -3.811 0.000
Alcohol consumption 0.110 0.034 0.144 3.250 0.001
Gender 0.228 0.054 0.213 4.196 0.000
Cigarette smoking 0.122 0.046 0.123 2.640 0.008
LDL-C Age 0.010 0.002 0.185 4.946 0.000
Body mass index 0.047 0.009 0.182 5.052 0.000
Blood glucose 0.050 0.019 0.094 2.624 0.009
Diastolic blood pressure 0.006 0.003 0.074 1.992 0.047
ApoAI Alcohol consumption 0.129 0.016 0.345 8.253 0.000
Body mass index -0.014 0.003 -0.175 -4.997 0.000
Cigarette smoking 0.088 0.021 0.182 4.119 0.000
Gender 0.099 0.025 0.189 3.942 0.000
ApoB Body mass index 0.018 0.002 0.300 8.877 0.000
Blood glucose 0.023 0.004 0.182 5.433 0.000
Gender -0.046 0.016 -0.112 -2.819 0.005
Systolic blood pressure 0.001 0.000 0.093 2.446 0.015
Age 0.001 0.001 0.104 2.802 0.005
Alcohol consumption 0.026 0.012 0.089 2.230 0.026
ApoAI/ApoB Body mass index -0.050 0.005 -0.323 -9.364 0.000
Age -0.004 0.001 -0.112 -3.234 0.001
Blood glucose -0.026 0.011 -0.082 -2.347 0.019
Gender 0.273 0.049 0.264 5.575 0.000
Cigarette smoking 0.154 0.042 0.161 3.683 0.000
Alcohol consumption 0.098 0.031 0.133 3.225 0.001
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B
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Page 11 of 15the two ethnic groups. The subjects with GT/TT geno-
types in Mulao had higher serum levels of HDL-C,
ApoAI, and the ratio of ApoAI to ApoB than the sub-
jects with GG genotype in males but not in females.
The T allele carriers in Han had higher serum levels of
TC, TG, LDL-C, ApoAI, and ApoB than the T allele
noncarriers in males but not in females. These lipid
parameters were also correlated with the genotypes in
males but not in females. These results suggest that
there is a sex-specific association of rs16996148 SNP in
the NCAN/CILP2/PBX4 and serum lipid levels in our
study populations.
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